Janssen is a sponsor of the World Neuroscience Innovation Forum on March 27, 2017, in London. The conference will cover the latest in neuroscience research and innovation. The goal of the London Forum is to spark new insights, therapeutic paths and collaborations to combat neuroinflammation and neurodegeneration found in diseases such as Alzheimer’s and multiple sclerosis. The Forum will highlight the latest clinical trial findings on early stage Alzheimer’s drugs and next steps with global CEO’s, industry experts and business leaders, including Dr. Husseini Manji, our global therapeutic area head for neuroscience. To learn more, click go to neuroscienceinnovationforum.org